Cargando…
Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
High-throughput detection of neutralizing antibodies against SARS-CoV-2 presents a valuable tool for vaccine trials or investigations of population immunity. We evaluate the performance of the first commercial surrogate virus neutralization test (sVNT, GenScript Biotech) against SARS-CoV-2 plaque re...
Autores principales: | Hofmann, Natalie, Grossegesse, Marica, Neumann, Markus, Schaade, Lars, Nitsche, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894493/ https://www.ncbi.nlm.nih.gov/pubmed/35241780 http://dx.doi.org/10.1038/s41598-022-07597-3 |
Ejemplares similares
-
Application of spectral library prediction for parallel reaction monitoring of viral peptides
por: Grossegesse, Marica, et al.
Publicado: (2021) -
Combined Proteomics/Genomics Approach Reveals Proteomic Changes of Mature Virions as a Novel Poxvirus Adaptation Mechanism
por: Grossegesse, Marica, et al.
Publicado: (2017) -
A Next-Generation Sequencing Approach Uncovers Viral Transcripts Incorporated in Poxvirus Virions
por: Grossegesse, Marica, et al.
Publicado: (2017) -
An ELISA Platform for the Quantitative Analysis of SARS-CoV-2 RBD-neutralizing Antibodies As an Alternative to Monitoring of the Virus-Neutralizing Activity
por: Kostin, N. N., et al.
Publicado: (2022) -
Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
por: Kulkarni, Ruta, et al.
Publicado: (2021)